# First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome

> **NCT01651637** · PHASE1 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 40 (actual)

## Conditions studied

- Respiratory Distress Syndrome in Premature Infants

## Interventions

- **DRUG:** synthetic surfactant (CHF5633)

## Key facts

- **NCT ID:** NCT01651637
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2015-01-23
- **Final completion:** 2015-01-23
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01651637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01651637, "First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01651637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*